ETTX · Categories · Form 4

ETTX - SEC Form 4 insider transactions

Entasis Therapeutics Holdings Inc. (ETTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ETTX

• 1427d
  SEC Form 4: Innoviva, Inc. bought $42,395,047 worth of shares (19,270,476 units at $2.20)

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Wagner Kristie Ann returned 80,500 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Triola Anna Diaz returned 125,000 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Tommasi Ruben returned 150,000 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Ronsheim Matthew returned 150,000 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Perros Manoussos returned 478,500 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Mueller John Patrick returned 150,000 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Meek David D. returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Mayer Howard returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Keiley Elizabeth M returned 150,000 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Hastings David C returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Berger Heather A. returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1429d
  SEC Form 4: Altarac David returned 150,000 shares to the company, closing all direct ownership in the company

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1565d
  SEC Form 4: Wagner Kristie Ann was granted 10,000 shares, increasing direct ownership by 14% to 80,500 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1567d
  SEC Form 4 filed by Innoviva, Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Meek David D.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Entasis Therapeutics Holdings Inc.

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1575d
  SEC Form 4 filed by Keiley Elizabeth M

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Tommasi Ruben was granted 125,000 shares, increasing direct ownership by 194% to 189,596 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Gutch Michael was granted 125,000 shares, increasing direct ownership by 294% to 167,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Ronsheim Matthew was granted 125,000 shares, increasing direct ownership by 294% to 167,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Perros Manoussos was granted 125,000 shares, increasing direct ownership by 31% to 534,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Mueller John Patrick was granted 125,000 shares, increasing direct ownership by 297% to 167,092 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Mayer Howard was granted 27,500 shares, increasing direct ownership by 125% to 49,500 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Behanna Heather was granted 27,500 shares, increasing direct ownership by 125% to 49,500 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Keiley Elizabeth M was granted 125,000 shares, increasing direct ownership by 294% to 167,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Meek David D. was granted 27,500 shares, increasing direct ownership by 125% to 49,500 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Hastings David C was granted 27,500 shares, increasing direct ownership by 125% to 49,500 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Altarac David was granted 125,000 shares, increasing direct ownership by 294% to 167,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1602d
  SEC Form 4: Triola Anna Diaz was granted 125,000 shares

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Ronsheim Matthew covered exercise/tax liability with 3,669 shares, decreasing direct ownership by 8% to 42,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Altarac David covered exercise/tax liability with 3,669 shares, decreasing direct ownership by 8% to 42,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Keiley Elizabeth M covered exercise/tax liability with 3,669 shares, decreasing direct ownership by 8% to 42,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Mueller John Patrick covered exercise/tax liability with 3,907 shares, decreasing direct ownership by 8% to 42,092 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Perros Manoussos covered exercise/tax liability with 11,704 shares, decreasing direct ownership by 8% to 135,822 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Gutch Michael covered exercise/tax liability with 3,669 shares, decreasing direct ownership by 8% to 42,572 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1679d
  SEC Form 4: Tommasi Ruben covered exercise/tax liability with 3,669 shares, decreasing direct ownership by 5% to 64,596 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Perros Manoussos was granted 79,750 shares and sold $38,197 worth of shares (11,974 units at $3.19), increasing direct ownership by 85% to 147,526 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Mueller John Patrick sold $12,763 worth of shares (4,001 units at $3.19) and was granted 25,000 shares, increasing direct ownership by 84% to 45,999 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Gutch Michael was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Tommasi Ruben was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 45% to 68,265 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Keiley Elizabeth M was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Altarac David was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1693d
  SEC Form 4: Ronsheim Matthew was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1785d
  SEC Form 4 filed by Triola Anna Diaz

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1824d
  SEC Form 4: Innoviva, Inc. bought $12,537,950 worth of Common Stock (6,268,975 units at $2.00)

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1846d
  SEC Form 4: Innoviva, Inc. bought $7,462,050 worth of Common Stock (3,731,025 units at $2.00)

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1895d
  SEC Form 4: Howard Mayer was granted 22,000 units of Common Stock

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1895d
  SEC Form 4: Heather Behanna was granted 22,000 units of Common Stock

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1895d
  SEC Form 4: D. David Meek was granted 22,000 units of Common Stock

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1895d
  SEC Form 4: C David Hastings was granted 22,000 units of Common Stock

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)
• 1967d
  SEC Form 4: Ruben Tommasi was granted 25,000 units of Common Stock, increasing ownership by 114% to 47,024 units

  4 - Entasis Therapeutics Holdings Inc. (0001724344) (Issuer)

Other ETTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends